Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: LEO Pharma Expands Market Reach Through Bayer Dermatology Deal

Jul 31 2018

• By Scrip Team

DealWatch_1200x675

Related Content

Keeping Track: Vitaros Reenters The Wilderness, Remoxy Gives It A Fourth Try, And Two Novel Approvals

Feb 19 2018

Executive Interview: Gitte Aabo On Leo Pharma's Innovation Strategy

Jan 09 2018

J&J/Janssen win OK for Sylvant; 1st US drug in Castleman's

Apr 24 2014

End In Sight: Humira Stacks Up 20 Years Of US Market Exclusivity

Apr 05 2018

Lysosomal Storage Disorders: Azafaros Takes Aim At Small Molecules

Jul 24 2018

Lilly Looks To Spin Off Animal Health, Focus Cash On Pharma Growth

Jul 25 2018

Nabriva Gains New CEO And Near-Market Antibiotic, Claims Leadership Role

Jul 25 2018

Five Reasons Why GSK Spinning Off Consumer Is Not So Straightforward

Jul 23 2018

Sangamo Buys TxCell To Get In Early on CAR-Tregs In Immunology

Jul 23 2018

Aurobindo Aims For Europe Growth With Apotex Acquisitions

Jul 16 2018

Deal Watch: Allergan Deal-Binge Includes Derm, NASH Buys

Sep 22 2016

Related Companies

LEO Pharma A/S

Bayer AG

Seelos Therapeutics, Inc.

Ligand Pharmaceuticals, Inc.

Anima Biotech Inc.

Eli Lilly and Company

Sutro Biopharma, Inc.

Merck & Co., Inc.

AstraZeneca PLC

Cheplapharm Arzneimittel GmbH

Protalix BioTherapeutics, Inc.

Chiesi Farmaceutici S.p.A.

Johnson & Johnson

AbbVie Inc.

Viatris Inc.

Amgen, Inc.

Samsung Bioepis Co., Ltd.

Cambrex Corporation

Nabriva Therapeutics plc.

GSK plc

Sangamo Therapeutics, Inc.

TxCell SA

Aurobindo Pharma Limited

Apotex Inc.

Additional Topics

Deals M & A Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window